Dose Proportionality of Mycophenolate Mofetil in Renal Transplant Recipients

被引：0
|
作者：
de Winter, Brenda C. M. [1 ]
van Gelder, Teun [1 ,2 ]
Sombogaard, Ferdi [1 ]
van Hest, Reinier M. [1 ]
Mathot, Ron A. A. [1 ]
机构：
[1] Erasmus Univ, Med Ctr, Dept Hosp Pharm, Clin Pharmacol Unit, Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Internal Med, Renal Transplant Unit, Rotterdam, Netherlands
来源：
THERAPEUTIC DRUG MONITORING | 2009年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
31
引用
收藏
页码：613 / 613
页数：1
相关论文
共 50 条
  • [21] The use of mycophenolate mofetil in transplant recipients
    Mele, TS
    Halloran, PF
    IMMUNOPHARMACOLOGY, 2000, 47 (2-3): : 215 - 245
  • [22] Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients
    Johnson, DW
    Nicol, DL
    Preston, JM
    Brown, AM
    Hawley, CM
    Campbell, SB
    Wall, D
    Griffin, AD
    Isbel, NM
    TRANSPLANTATION, 2003, 76 (03) : 619 - 619
  • [23] The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients
    Tang, Jiang-Tao
    de Winter, Brenda C.
    Hesselink, Dennis A.
    Sombogaard, Ferdi
    Wang, Lan-Lan
    van Gelder, Teun
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (04) : 812 - 822
  • [24] Does mycophenolate mofetil increase the incidence of infections in renal transplant recipients?
    Prokopenko, E
    Scherbakova, E
    Vatazin, A
    Pasov, S
    Budnikova, N
    Agafonova, S
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 2005, 31 (5-6) : 199 - 205
  • [25] Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients
    Suhail, SM
    Vathsala, A
    Lou, HX
    Woo, KT
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1757 - 1758
  • [26] Abdominal pain is a critical complication of mycophenolate mofetil in renal transplant recipients
    Akioka, K
    Okamoto, M
    Nakamura, K
    Ushigome, H
    Kadotani, Y
    Ohmori, Y
    Yoshimura, N
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (01) : 300 - 301
  • [27] Effects of mycophenolate mofetil and azathioprine on the erythropoietin production in renal transplant recipients
    Montanaro, D
    Gropuzzo, M
    Tulissi, P
    Boscutti, G
    Risaliti, A
    Baccarani, U
    Sainz, M
    Mioni, G
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3253 - 3255
  • [28] Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients
    Sureshkumar, KK
    Nghiem, DD
    TRANSPLANTATION, 2003, 76 (02) : 441 - 442
  • [29] Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil
    Herrero, JI
    Quiroga, J
    Sangro, B
    Girala, M
    Gomez-Manero, N
    Pardo, F
    Alvarez-Cienfuegos, J
    Prieto, J
    LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (05): : 414 - 420
  • [30] Implications of Clinical Mycophenolate Mofetil Dose According to Individual Body Weight in Japanese Renal Transplant Recipients
    Yamada, S.
    Shiohira, H.
    Uehara, H.
    Hokama, N.
    Saitou, S.
    Ooshiro, Y.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (01) : 35 - 41
12345